Frank Karbe - Director at Phathom Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Frank Karbe since 7/7/2023

Holdings reported by Frank Karbe for Phathom Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 44,500 $452 K $10.16 May 29, 2024 Direct
Stock Option (Right to Buy) 17,500 May 23, 2024 Direct Common Stock

Transactions reported by Frank Karbe for Phathom Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership